Skip to main content
. 2019 Nov 15;7:320. doi: 10.3389/fbioe.2019.00320

Figure 1.

Figure 1

(A) Formation of PPHAuNC-TNC. (B) in vivo biodistribution of differently-sized PPHAuNCs-TNCs. After intravenous injection with (a) naked Cy5.5-miRNAs (control group), (b) PPHAuNCs-30-TNCs, (c) PPHAuNCs-50-TNCs, and (d) PPHAuNCs-70-TNCs.